A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival

Glioma is a lethal central nervous system tumor with poor patient survival prognosis. Because of the molecular heterogeneity, it is a challenge to precisely determine the type of the tumor and to choose the most effective treatment. Therefore, novel biomarkers are essential to improve the diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Valiulyte, Indre, Steponaitis, Giedrius, Kardonaite, Deimante, Tamasauskas, Arimantas, Kazlauskas, Arunas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582960/
https://www.ncbi.nlm.nih.gov/pubmed/33036421
http://dx.doi.org/10.3390/ijms21197396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582960/
https://www.ncbi.nlm.nih.gov/pubmed/33036421
http://dx.doi.org/10.3390/ijms21197396

Ejemplares similares